Literature DB >> 18625144

Patterns of gastrointestinal disease associated with mutations of CFTR.

Michael Wilschanski1.   

Abstract

This review focuses on the pathobiology of the gastrointestinal and hepatic manifestations of cystic fibrosis (CF) disease in relation to their genetic basis in mutations of the CF transmembrane conductance regulator (CFTR) gene. It reviews the nature of the CFTR protein, a categorization of the types of gene mutations underlying CF's various manifestations, and the ways in which absent or reduced CFTR produces various functional abnormalities in the different organs affected by CF. Subsequently, the particular organ-related clinical manifestations of CF directly associated with loss of CFTR function are addressed. Thereafter, the review discusses some of the complexities of the genotype-phenotype relationships related to milder mutations or complex genetic disorders in which CFTR abnormalities interact with other genetic and environmental factors, and the potential diagnostic roles of sweat testing or other electrophysiologic testing. This discussion examines secondary gastrointestinal manifestations of CF and the particular cases of diseases that may be related to abnormalities of CFTR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625144     DOI: 10.1007/s11894-008-0062-3

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  42 in total

Review 1.  The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.

Authors:  B J Rosenstein; G R Cutting
Journal:  J Pediatr       Date:  1998-04       Impact factor: 4.406

2.  Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.

Authors:  Kris De Boeck; Matijn Weren; Marijka Proesmans; Eitan Kerem
Journal:  Pediatrics       Date:  2005-03-16       Impact factor: 7.124

3.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.

Authors:  Michele D Bishop; Steven D Freedman; Julian Zielenski; Najma Ahmed; Annie Dupuis; Sheelagh Martin; Lynda Ellis; Julie Shea; Isobel Hopper; Mary Corey; Paul Kortan; Gregory Haber; Christine Ross; John Tzountzouris; Leslie Steele; Peter N Ray; Lap-Chee Tsui; Peter R Durie
Journal:  Hum Genet       Date:  2005-09-29       Impact factor: 4.132

5.  Appendicitis in cystic fibrosis.

Authors:  M D Shields; H Levison; J J Reisman; P R Durie; G J Canny
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

6.  Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Authors:  Sunil Sheth; Julie C Shea; Michele D Bishop; Sanjiv Chopra; Meredith M Regan; Emily Malmberg; Carolyn Walker; Ryan Ricci; Lap-Chee Tsui; Peter R Durie; Julian Zielenski; Steven D Freedman
Journal:  Hum Genet       Date:  2003-06-03       Impact factor: 4.132

7.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Distal intestinal obstruction syndrome in adults with cystic fibrosis.

Authors:  Xavier Dray; Thierry Bienvenu; Nadine Desmazes-Dufeu; Daniel Dusser; Philippe Marteau; Dominique Hubert
Journal:  Clin Gastroenterol Hepatol       Date:  2004-06       Impact factor: 11.382

9.  Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas.

Authors:  H Kopelman; M Corey; K Gaskin; P Durie; Z Weizman; G Forstner
Journal:  Gastroenterology       Date:  1988-08       Impact factor: 22.682

10.  Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

Authors:  R L Smyth; D van Velzen; A R Smyth; D A Lloyd; D P Heaf
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

View more
  3 in total

Review 1.  Animal models of biliary injury and altered bile acid metabolism.

Authors:  Valeria Mariotti; Mario Strazzabosco; Luca Fabris; Diego F Calvisi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-11       Impact factor: 5.187

2.  Increased levels of anti-glycan antibodies in patients with cystic fibrosis.

Authors:  T O Hirche; J Stein; H Hirche; J Hausmann; T O Wagner; F Behrens; Oliver Schröder
Journal:  Eur J Med Res       Date:  2011-09-12       Impact factor: 2.175

3.  Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.

Authors:  Thomas Flass; Suhong Tong; Daniel N Frank; Brandie D Wagner; Charles E Robertson; Cassandra Vogel Kotter; Ronald J Sokol; Edith Zemanick; Frank Accurso; Edward J Hoffenberg; Michael R Narkewicz
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.